Welcome to CDC stacks | Considerations for PCV13 use among adults ≥65 years old and a summary of the evidence to recommendations framework - 80462 | Advisory Committee on Immunization Practices (ACIP)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Considerations for PCV13 use among adults ≥65 years old and a summary of the evidence to recommendations framework
Filetype[PDF-643.45 KB]


Details:
  • Supporting Files:
    No Additional Files
You May Also Like: